Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Cronos Group (TSE:CRON) Stock Price Down 0.6% - Should You Sell?

Cronos Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

Cronos Group Inc. (TSE:CRON - Get Free Report)'s share price was down 0.6% on Monday. The company traded as low as C$4.62 and last traded at C$4.66. 106,484 shares traded hands during mid-day trading, a decline of 33% from the average session volume of 159,142 shares. The stock had previously closed at C$4.69.

Analyst Upgrades and Downgrades

Separately, TD upped their price objective on shares of Cronos Group from C$5.50 to C$6.00 and gave the company a "buy" rating in a research note on Monday, August 10th. Three investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of C$4.92.

View Our Latest Analysis on CRON

Cronos Group Stock Performance

The company has a market capitalization of C$1.72 billion, a PE ratio of 24.53, a P/E/G ratio of 0.12 and a beta of 1.29. The company has a debt-to-equity ratio of 0.12, a quick ratio of 24.01 and a current ratio of 16.18. The stock's 50-day simple moving average is C$4.62 and its 200 day simple moving average is C$3.95.

Cronos Group (TSE:CRON - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported C$0.13 earnings per share for the quarter. The business had revenue of C$75.31 million during the quarter. Cronos Group had a net margin of 38.95% and a return on equity of 6.46%. As a group, research analysts expect that Cronos Group Inc. will post -0.26 earnings per share for the current fiscal year.

About Cronos Group

(Get Free Report)

Cronos is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT and Lord Jones. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines